Shuttle Pharmaceuticals ...

NASDAQ: SHPH · Real-Time Price · USD
3.34
-0.16 (-4.57%)
At close: Aug 15, 2025, 3:01 PM

Shuttle Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Cash & Equivalents
4.82M 4.51M 1.92M 156.66K 695.59K 1.4M 2.58M 3.89M 5.45M 7.17M 8.42M 9.12M 50.44K 405.86K 504.75K
Short-Term Investments
n/a n/a n/a n/a 1.64M 2.79M 2.89M 2.92M 2.9M 2.99M n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
48.49K 71.88K n/a n/a n/a 81.53K n/a n/a n/a 13.69K 6.48K 6.48K 6.48K 6.48K 6.48K
Receivables
n/a n/a n/a 4.00 7.23K 11.96K 14.9K 12.44K 6.95K 7.02K n/a 5.95K n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a 170.1K 78.95K -7.02K n/a n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a 101.65K n/a n/a n/a -163.62K 6.48K n/a n/a n/a n/a n/a n/a
Total Current Assets
5.19M 4.96M 2.21M 361.35K 2.49M 4.33M 5.59M 7M 8.44M 10.37M 8.58M 9.29M 63.95K 426.47K 509.62K
Property-Plant & Equipment
264.02K 278.91K 295.37K 312.22K 327.67K 342.9K 358.73K 380.21K 393.76K 50.93K 68.71K 86.05K 103.05K 119.5K 135.55K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
312.51K 350.79K 295.37K 312.22K 327.67K 424.44K 358.73K 380.21K 393.76K 64.62K 75.19K 92.53K 109.53K 125.98K 142.03K
Total Assets
5.5M 5.31M 2.51M 673.57K 2.81M 4.75M 5.95M 7.38M 8.84M 10.44M 8.65M 9.38M 173.48K 552.45K 651.64K
Account Payables
1.17M 896.88K 596.6K 1.35M 364.89K 347.56K 283.31K 180K 88.74K 447.47K 129.25K 107.15K 515.79K 691.2K 828.31K
Deferred Revenue
n/a n/a n/a n/a -62.09K n/a n/a n/a -88.74K n/a n/a n/a n/a n/a 378.56K
Short-Term Debt
517.82K 820.86K 874.48K 250K 826.24K 941.4K 596K 462.82K 329.43K 801.5K 748.3K 759.18K 1.26M 1.11M 849.5K
Other Current Liabilities
590.00 n/a n/a n/a 62.6K 2.04K n/a n/a -61.03K -44.63K -62.82K -73.71K 112.8K 54.37K 94.03K
Total Current Liabilities
1.69M 1.78M 1.53M 1.66M 1.38M 1.49M 1.04M 810.44K 493.68K 1.39M 975.68K 970.47K 2.45M 2.36M 2.22M
Long-Term Debt
195.16K n/a n/a n/a n/a n/a 135.09K 134.38K 122.31K 751.69K n/a n/a n/a n/a n/a
Other Long-Term Liabilities
10.96K 22.64K 25.28K 74.11K 359.92K 214.62K 414.51K 512.83K 955.73K 1.39M n/a n/a n/a n/a n/a
Total Long-Term Liabilities
206.12K 242.75K 263.37K 329.71K 626.94K 503.22K 853.73K 955.63K 1.41M 2.14M 865.04K 6.67K 25.6K 44.25K 62.44K
Total Liabilities
1.9M 2.02M 1.8M 1.99M 2.01M 1.99M 1.9M 1.77M 1.9M 3.53M 975.68K 977.14K 2.48M 2.4M 2.28M
Total Debt
712.98K 1.1M 1.17M 564.26K 1.16M 1.28M 1.09M 966.67K 781.51K 1.55M 748.3K 765.85K 1.36M 1.23M 978.88K
Common Stock
11.00 63.00 41.00 29.00 21.00 168.00 20.00 160.00 155.00 137.00 136.00 136.00 93.00 93.00 93.00
Retained Earnings
-41.34M -37.63M -34.58M -32.98M -29.2M -17.22M -25.43M -13.85M -12.05M -9.87M -8.89M -8.14M -7.13M -6.5M -5.8M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 16.34K
Shareholders Equity
3.61M 3.29M 709.15K -1.32M 801.43K 2.76M 4.06M 5.61M 6.94M 6.91M 7.68M 8.4M -2.31M -1.85M -1.63M
Total Investments
n/a n/a n/a n/a 1.64M 2.79M 2.89M 2.92M 2.9M 2.99M n/a n/a n/a n/a n/a